rAAV.caTPP1

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamerAAV.caTPP1
Drug Alias NamerAAV expressing canine TPP1 (Childrens Hospital of Philadelphia)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionTripeptidyl Peptidase 1 stimulants
TargetsTripeptidyl Peptidase 1
Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChildrens Hospital of Philadelphia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChildrens Hospital of Philadelphia
Active IndicationsN/A
Inactive IndicationsNeuronal Ceroid-Lipofuscinoses

Other Information

ATC CodeN/A
Related LinksN/A